Although transplantation of human mesenchymal stem cells (MSCs) derived from amnion
(hAMSCs), bone marrow (hBMSCs) and adipose tissues (hADSCs) has been shown to aid …

Wound healing remains a major challenge in modern medicine. Bone marrow‐(BM) and
adipose tissue‐(AT) derived mesenchymal stromal/stem cells (MSCs) are of great interest for …

Our understanding of the role of bone marrow (BM)-derived cells in cutaneous homeostasis
and wound healing had long been limited to the contribution of inflammatory cells. Recent …

Skin disease may be related with immunological disorders, external aggressions, or genetic
conditions. Injuries or cutaneous diseases such as wounds, burns, psoriasis, and …

Mesenchymal stromal cells (MSCs) have shown to be a promising tool in cell therapies to
treat different conditions. Several pre-clinical and clinical studies have proved that the …

Chronic wounds are a source of substantial morbidity for patients and are a major financial
burden for the healthcare system. There are no current therapies that reliably improve …

Cutaneous wounds requiring tissue replacement are often challenging to treat and result in
substantial economic burden. Many of the challenges inherent to therapy-mediated healing …

Although bone marrow-derived mesenchymal stem cells have been shown to promote
repair when applied to cutaneous wounds, the mechanism for this response remains to be …

Abstract Background Mesenchymal stem cells (MSCs) are multipotent stem cells able to
differentiate into different cell lineages. However, MSCs represent a subpopulation of a more …

Although advancements have been made with traditional therapies, the treatment of chronic
nonhealing wounds still remains a tough challenge. In the past two decades, mesenchymal …